FDA 483 - Alcami Carolinas Corporation - October 29, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Alcami Carolinas Corporation in Charleston, SC, a drug manufacturer, revealed four significant observations. The firm was cited for inadequate validation of sterilization processes, failure to calibrate instruments at suitable intervals, not following test procedures for pyrogens, and improper handling of microbial identification samples. These issues indicate deficiencies in the firm's quality control and manufacturing practices for sterile drug products.
- Office
- Atlanta District Office
- Person
ID · d9e81f65-45dd-4025-a4f2-4ad66bd4da9c